[
  {
    "My Clinical Question (condition: sexual health)": "***"
  },
  {
    "My most current assessment of this problem can be found in the note dated": "{Today/***}"
  },
  {
    "In your clinical question, or current note, please include information on": {
      "Assessments": {
        "Required": [],
        "Optional": []
      },
      "Diagnostics": {
        "Required": [],
        "Optional": [
          {
            "CMP": "***"
          },
          {
            "HIV Antigen/Antibody Screen": "***"
          },
          {
            "HIV RNA Quant (viral load)": "***"
          },
          {
            "Hep C Ab IgG": "***"
          },
          {
            "Hepatitis B Surface Antigen (HBsAg)": "***"
          },
          {
            "Syphilis Treponemal Screen (STSS)": "***"
          },
          {
            "Chlamydia/GC NAAT (Urine, Oropharyngeal Swab, Rectal Swab)": "***"
          }
        ]
      },
      "Clinical Pearls": [
        {
          "Detailed information about PrEP for clinicians can be found at https://www.cdc.gov/hiv/clinicians/prevention/prep.html for details regarding PrEP": "***"
        },
        {
          "Patients on PrEP should have HIV testing every 3 months to screen for breakthrough cases of HIV": "***"
        },
        {
          "Patients on PrEP with FTC-TDF (Truvada) should have a BMP/Cystatin-C every 3 months to monitor renal function": "***"
        },
        {
          "Consider STI testing for syphilis, gonorrhea, and chlamydia every 3 months for patients who state that they are at risk. Remember that gonorrhea and chlamydia must be tested by site": "***"
        }
      ]
    }
  }
]
